Wednesday, September 5, 2007

No need for aggressive bullying tactics



The keenly-watched Novartis litigation in Indian courts offers us lessons for patent strategy, says Mr Shamnad Basheer, an expert in IP (intellectual property) law. The patent saga of the global major teaches us that pharmaceutical companies and patent lawyers representing them cannot remain obsessed with technical nuan ces of patent law, he adds.

“Rather, a successful patent strategy will be one that works within the framework of an increasingly politicised patent regime to yield results that help generate more goodwill for the pharmaceutical company,” explains Mr Bashee r, in an email interaction with Business Line. He is Frank H. Marks Visiting Associate Professor in Law in George Washington University Law School, Washington DC, US.

No comments: